Scientia Disilvestro, P, Banerjee, S, Colombo, N, Scambia, G, Kim, B, Oaknin, A, Friedlander, M, Lisyanskaya, A, Floquet, A, Leary, A, Sonke, G S, Gourley, C, Oza, A, González-martín, A, Aghajanian, C, Bradley, W, Mathews, C, Liu, J, Mcnamara, J, Lowe, E S, Ah-see, M & Moore, K N 2022, ' Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial ', Journal of Clinical Oncology . https://doi.org/10.1200/JCO.22.01549
Lancet Oncology, 23, 8, pp. e374-e384 Vergote, I, Gonzalez-Martin, A, Lorusso, D, Gourley, C, Raza Mirza, M, Kurtz, J-E, Okamoto, A, Moore, K, Kridelka, F, McNeish, I, Reuss, A, Votan, B, du Bois, A, Mahner, S, Ray-Coquard, I, C. Kohn, E, S Berek, J, SP Tan, D, Colombo, N, Zang, R, Concin, N, O'Donnell, D, Rauh-Hain, A, Herrington, C S, Marth, C, Poveda, A, Fujiwara, K, C.E Stuart, G, Oza, A & Bookman, M A 2022, ' Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup ', The Lancet Oncology, vol. 23, no. 8, pp. e374-e384 . https://doi.org/10.1016/S1470-2045(22)00139-5 Lancet Oncology, 23, e374-e384
Colombo, N, Moore, K, Scambia, G, Oaknin, A, Friedlander, M, Lisyanskaya, A, Floquet, A, Leary, A, Sonke, G S, Gourley, C, Banerjee, S, Oza, A, González-martín, A, Aghajanian, C, Bradley, W H, Kim, J, Mathews, C, Liu, J, Lowe, E S, Bloomfield, R & Disilvestro, P 2021, ' Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trial ', Gynecologic Oncology . https://doi.org/10.1016/j.ygyno.2021.07.016 Scientia